Development and Regulation of Abuse-Deterrent Formulations of Opioid Medications; Public Meeting

9 organizations filed 9 public comments on Development and Regulation of Abuse-Deterrent Formulations of Opioid Medications; Public Meeting, at the Food and Drug Administration. The comment window closed 4218d ago.

Commenters (9)

• 3M Drug Delivery Systemsunverified attribution

  1 filing · confidence 70%
• American Osteopathic Associationtrade assoc.

  1 filing · confidence 85%
• American Pharmacists Association (APhA)trade assoc.

  1 filing · confidence 97%
• Amneal Pharmaceuticals LLCunverified attribution

  1 filing · confidence 70%
• Generic Pharmaceutical Associationtrade assoc.

  1 filing · confidence 85%
• Osmotica Pharmaceutical Corporationunverified attribution

  1 filing · confidence 70%
• Par Pharmaceutical Incunverified attribution

  1 filing · confidence 70%
• Pfizer Inc.unverified attribution

  1 filing · confidence 70%
• US Pain Foundationtrade assoc.

  1 filing · confidence 85%